Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of antiepileptic and anticonvulsant drugs. Its structural configuration allows for selective interaction with neurological targets, enhancing drug efficacy and reducing side effects. Commonly employed in the preparation of beta-amino acid derivatives that exhibit improved metabolic stability and bioavailability. Also utilized in research settings for the design of enzyme inhibitors and peptidomimetic compounds.